Volume | 707,973 |
|
|||||
News | - | ||||||
Day High | 50.75 | Low High |
|||||
Day Low | 50.05 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Globus Medical Inc | GMED | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
50.75 | 50.05 | 50.75 | 50.48 | 50.43 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
14,738 | 707,973 | US$ 50.41 | US$ 35,687,332 | - | 43.385 - 62.88 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:00:00 | 95,079 | US$ 50.48 | USD |
Globus Medical Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
6.83B | 135.37M | - | 1.57B | 122.87M | 0.91 | 55.60 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Globus Medical News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GMED Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 51.23 | 51.29 | 49.33 | 50.37 | 630,036 | -0.75 | -1.46% |
1 Month | 52.77 | 54.16 | 49.33 | 51.48 | 849,087 | -2.29 | -4.34% |
3 Months | 52.53 | 57.375 | 49.33 | 52.88 | 1,017,381 | -2.05 | -3.90% |
6 Months | 46.62 | 57.46 | 43.385 | 51.33 | 1,145,125 | 3.86 | 8.28% |
1 Year | 57.905 | 62.88 | 43.385 | 53.07 | 1,317,456 | -7.43 | -12.82% |
3 Years | 72.43 | 84.23 | 43.385 | 59.73 | 912,418 | -21.95 | -30.31% |
5 Years | 44.22 | 84.23 | 33.41 | 56.90 | 820,989 | 6.26 | 14.16% |
Globus Medical Description
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. |